Risk factor
Strong & resilient to price shocks
Profitability factor
Greatly overvalued vs peers
About
Qingdao Haier Biomedical Co., Ltd. specializes in the global development, production, sales, and distribution of low-temperature storage solutions for critical biomedical samples. Their extensive product portfolio includes a range of freezers—such as cryogenic, ultra-low temperature, biomedical, spark-free, vaccine, and plasma models—along with refrigerators designed for laboratories, pharmacies, blood banks, and vaccine storage. They also provide blood/fluid warming cabinets, essential backup systems, consumables, and specialized cold/freezer rooms, alongside comprehensive vaccine safety solutions and plasma apheresis systems. Beyond storage, the company delivers various healthcare innovations, including intelligent mobile inoculation clinics, refrigerated vaccine transport vehicles, advanced vaccine shelters, P2+ mobile nucleic acid testing vehicles, smart autonomous disinfection units, and air purification sterilizers. Their offerings further extend to medical diagnostic and support tools like infrared thermometers, blood pressure monitors, and oxygen concentrators, as well as biosafety screening booths, solar-powered medical laboratories, mobile PCR testing labs, and versatile mobile container clinics. Complementing these, they supply a selection of general laboratory equipment and transport coolers. Established in 2005, Qingdao Haier Biomedical Co., Ltd. is headquartered in Qingdao, China. Separately, Inner Mongolia Baotou Steel Union Co., Ltd. operates as a subsidiary of Baotou Iron and Steel (Group) Co., Ltd.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.